Q3 2025 Troax Group AB (publ) Earnings Call Transcript

Oct 29, 2025 / 12:00PM GMT
Release Date Price: kr308.7

Key Points

Positve
  • Troax Group AB (FRA:5TOA) reported a strong order intake growth in the APEC region, up 66%, with all segments and countries showing positive development.
  • The company delivered a robust cash flow, achieving 122% cash conversion of EBITDA, indicating strong financial management.
  • A cost reduction program launched in the second quarter is delivering as planned, with sales and administrative costs starting to decrease.
  • Troax Group AB (FRA:5TOA) has set ambitious long-term financial targets, aiming for at least EUR 550 million in sales by 2030, with a 15% CAGR.
  • The warehousing segment in Europe is showing signs of recovery, with increased activity expected to translate into orders, making the company cautiously optimistic about future growth.
Negative
  • The company experienced a 7% decline in order intake and sales, with 6% being organic and 1% due to negative FX effects.
  • Profitability was impacted by operational challenges in North America, including issues with pricing implementation and factory transfer, diluting the EBITDA margin.
  • The automotive and construction sectors in Europe and the Americas continue to be sluggish, contributing to a decline in order intake.
  • A negative one-off effect due to cutoff effects impacted the order intake numbers, as the company transitions operations to Sweden.
  • The US market is experiencing hesitancy in decision-making, with significant deals not converting into orders, affecting overall performance.
Martin NystrÃ;m Troax Group AB;President and CEO

¶-

And welcome to the 3rd quarter interim report for TOX Group. My name is Martin Nystrom, and together with Anders Yov, our CFO, we will present the numbers and key events for the 3rd quarter.

After the presentation, we will open up for a Q&A session which I will lead.

So let's dive into the quarterly numbers.

If I start with the 3rd quarter, I'd say that.

It's market development and we had some mixed outcomes.

In total, we reported a 7 order intake growth, and but this is distributed very differently. So if we start with the big exclamation point, AEC continued very strongly in the quarter, I think it was also very good to see a broad-based and significant growth in all the countries. So I think this is a good.

A good sign and also a good sign of the value proposition that we also did. We continued largely as we did in the second quarter.

Overall, I consider this to be expected recoveries. We're still waiting during the quarter in Europe.

We did see a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot